Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | gonadotropin-releasing hormone receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | GnHR receptor homolog | Get druggable targets OG5_131719 | All targets in OG5_131719 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosine kinase | 0.033 | 0.0146 | 0.0146 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0726 | 1 | 1 |
Mycobacterium ulcerans | adenosine deaminase | 0.0538 | 0.5317 | 0.5 |
Plasmodium vivax | adenosine deaminase, putative | 0.0538 | 0.5317 | 0.5 |
Brugia malayi | GnHR receptor homolog | 0.0668 | 0.8564 | 0.8543 |
Leishmania major | adenine aminohydrolase | 0.0538 | 0.5317 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0363 | 0.0954 | 0.082 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0538 | 0.5317 | 0.5 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0538 | 0.5317 | 0.5 |
Schistosoma mansoni | adenosine deaminase | 0.0538 | 0.5317 | 0.5317 |
Schistosoma mansoni | tyrosine kinase | 0.033 | 0.0146 | 0.0146 |
Echinococcus multilocularis | adenosine deaminase | 0.0538 | 0.5317 | 0.5248 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0538 | 0.5317 | 0.5 |
Echinococcus multilocularis | insulin receptor | 0.0726 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0363 | 0.0954 | 0.082 |
Schistosoma mansoni | adenosine deaminase-related | 0.0538 | 0.5317 | 0.5317 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0538 | 0.5317 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0726 | 1 | 1 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0538 | 0.5317 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0538 | 0.5317 | 0.5 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0726 | 1 | 1 |
Echinococcus granulosus | adenosine deaminase | 0.0538 | 0.5317 | 0.5248 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0538 | 0.5317 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0363 | 0.0954 | 0.082 |
Schistosoma mansoni | tyrosine kinase | 0.033 | 0.0146 | 0.0146 |
Schistosoma mansoni | tyrosine kinase | 0.0726 | 1 | 1 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0538 | 0.5317 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0538 | 0.5317 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0402 | 0.1923 | 0.1803 |
Loa Loa (eye worm) | hypothetical protein | 0.0363 | 0.0954 | 0.082 |
Treponema pallidum | adenosine deaminase | 0.0538 | 0.5317 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0538 | 0.5317 | 0.5248 |
Plasmodium falciparum | adenosine deaminase | 0.0538 | 0.5317 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.1777 | 0.1655 |
Brugia malayi | Adenosine/AMP deaminase family protein | 0.0538 | 0.5317 | 0.5248 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0726 | 1 | 1 |
Echinococcus granulosus | insulin receptor | 0.0726 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 1500 nM | Binding affinity evaluated by the ability to inhibit des-Gly10[125I-Tyr5,D-Leu6,NMeLeu7,Pro9-NEt]- Gonadotropin-releasing hormone binding to cloned human Gonadotropin-releasing hormone receptor expressed in HEK293 cells | ChEMBL. | 14971906 |
Ki (binding) | = 1500 nM | Binding affinity evaluated by the ability to inhibit des-Gly10[125I-Tyr5,D-Leu6,NMeLeu7,Pro9-NEt]- Gonadotropin-releasing hormone binding to cloned human Gonadotropin-releasing hormone receptor expressed in HEK293 cells | ChEMBL. | 14971906 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.